跳至主要内容
临床试验/ACTRN12621000244808
ACTRN12621000244808进行中(未招募)未知

Effect of periodontitis treatment on histone deacetylase expression levels in patients with periodontal disease: a prospective clinical study

niversity of Queensland0 个研究点目标入组 40 人开始时间: 2021年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
35 Years 至 o limit(—)
性别
All

入选标准

  • Patients 35 years of age or older.
  • For the periodontal health group:
  • No history of Stage III and IV periodontitis. BOP<10% and PPD<=3mm
  • For the gingivitis group*:
  • >=30% BOP and PPD<=3mm
  • For the periodontitis group*:
  • Generalised Stage III and IV Periodontitis, defined by:
  • >=30% sites with interdental CAL of at least 1-2mm and radiographic bone loss.
  • Interdental CAL >=5mm
  • Radiographic bone loss extending to middle third of root and beyond
  • Tooth loss due to periodontitis
  • Probing depths >=6mm
  • Class II or III furcation involvement
  • *Based on Chapple et al 2018

排除标准

  • Current smokers
  • Uncontrolled diabetes (HbA1c>=6.5)*
  • Long-term use of immunosuppressive or anti-inflammatory drugs, periodontal treatment or antibiotics therapy six months prior to investigation
  • *Based on American Diabetes Association 2018

研究者

发起方
niversity of Queensland

相似试验